Olpha

Olpha

Olpha Grupa is a leading Baltic pharmaceutical group with over 50 years of experience, offering more than 600 products across 14 therapeutic areas. Operating in 60+ markets, it includes specialized companies like Silvanols, Tonus Elast, and Rīgas Farmaceitiskā Fabrika.

Overview

Olpha Grupa is a prominent Baltic pharmaceutical group, formerly known as Olainfarm, with over 50 years of experience in the pharmaceutical industry. The group comprises several specialized companies, each focusing on distinct areas of the healthcare sector, thereby covering a broad spectrum of products and services. Key Companies in the Olpha Grupa: SIA Silvanols: Specializes in the development and production of dietary supplements, medical devices, cosmetics, and over-the-counter (OTC) medicines using natural ingredients to harness the healing power of nature. SIA Tonus Elast: One of the largest manufacturers of elastic medical products in Northern Europe, offering a range of products from bandages and compression stockings to complex back support items. AS Rīgas Farmaceitiskā Fabrika: A manufacturer of herbal-based products with over 70 years of experience, combining the power of nature with science to create effective healthcare solutions. SIA Jonnex-Farma: A pharmaceutical company experienced in the development and production of dietary supplements, medical devices, cosmetics, and OTC medicines using natural ingredients. Operational Highlights: Product Portfolio: Over 600 products across 14 therapeutic areas, including urology, cardiology, oncology, neurology, and more. Global Presence: Operations in 60+ export markets with local subsidiaries in countries such as 45, 49, 120, 66, 141, and Lithuania. Workforce: A dedicated team of over 1,400 employees committed to quality and innovation. Manufacturing Capabilities: Continuous 24/7 production capacity, ensuring consistent supply to meet global demand. Financial Performance: Achieved a net consolidated turnover of €120.25 million in 2022 and plans to invest €100 million in development projects from 2023 to 2028. Olpha Grupa's mission is to make quality healthcare accessible to all, leveraging its extensive experience, specialized companies, and commitment to innovation and quality. The group's strategic investments and global expansion efforts aim to position it among the top pharmaceutical companies in Europe.

Contact Details

Contact Person

Name: Elena Bushberg
Email: N/A

Contact: N/A
Company Email: olpha@olpha.eu

  • Overview
  • Contact Details
Ad
Advertisement

Write a Review